Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Voros, Szilard ^a   Yang, Zequan ^a   Bove, Christina M ^a   Gilson, Wesley D ^a   Epstein, Frederick H ^a   French, Brent A ^a   Berr, Stuart S ^a   Bishop, Sanford P ^b   Conaway, Mark R ^a   Matsubara, Hiroaki ^c   Carey, Robert M ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b University of Alabama at Birmingham   (United States)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Angiotensin; Magnetic resonance imaging; Myocardial infarction; Receptors

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; COLLAGEN; DRINKING WATER; GADOLINIUM; LOSARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; HEART LEFT VENTRICLE FUNCTION; METABOLISM; PHYSIOLOGY;

ANIMALS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33645740065     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00886.2005     Document Type: Article

References (30)

1. Adachi Y, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakanishi M, Nakagawa Y, Tanimoto K, Saitoh Y, Yasuno S, Usami S, Iwai M, Horiuchi M, and Nakao K. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 107: 2406-2408, 2003.
2. Bove CM, Yang Z, Gilson WD, Epstein FH, French B, Berr SS, Bishop SP, Matsubara H, Carey RM, and Kramer CM. Nitric oxide mediates benefits of angiotensin II type 2 receptor in post-infarct remodeling. Hypertension 43: 680-685, 2004.
3. 2) angiotensin receptor. Acta Physiol Scand 168: 65-71, 2000.
4. Harada K, Sugaya T, Murakami K, Yazaki Y, and Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 100: 2093-2099, 1999.
5. Ichihara S, Senbonmatsu T, Price E Jr, Ichicki T, Gaffney A, and Inagami T. Targeted deletion of angiotensin type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 106: 2244-2249, 2002.
6. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, and Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
7. 2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 32: 1787-1796, 1998.
8. Johren O, Dendorfer A, and Dominiak P. Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res 62: 460-467, 2004.
9. 1 receptor blockade. J Mol Cell Cardiol 37: 1023-1030, 2004.
10. 2 receptors during reperfused myocardial infarction. Mol Cell Biochem 260: 111-118, 2004.
11. Kramer CM, Lima JAC, Reichek N, Ferrari VA, Palmon LC, Yeh IT, Tallant B, and Axel L. Regional function within noninfarcted myocardium during left ventricular remodeling. Circulation 88: 1279-1288, 1993.
12. Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M, Roberts R, and Marian AJ. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103: 789-791, 2001.
13. Liu YH, Yang XP, Sharov VG, Nass O, Shabbah HN, Peterson E, and Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. J Clin Invest 99: 1926-1935, 1997.
14. Liu YH, Yang XP, Shesely E, Sankey SS, and Carretero OA. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. J Am Coll Cardiol 43: 1473-1480, 2004.
15. Mankad S, d'Amato T, Reichek N, McGregor W, Lin J, Singh D, Rogers WJ, and Kramer CM. Combining angiotensin II receptor antagonism and angiotensin converting enzyme inhibition further attenuates post-infarction left ventricular remodeling. Circulation 103: 2845-2850, 2001.
16. 1 receptor-mediated pressor and chronotropic effects. J Clin Invest 101: 527-535, 1998.
17. Matsubara H. Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes. Circ Res 88: 861-863, 2001.
18. 2 receptor in postinfarction left ventricular remodeling. Hypertension 41: 814-818, 2003.
19. Pfeffer MA, Lamas GA, and Vaughan DE. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319: 80-86, 1988.
20. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau J, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, and the Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349: 1893-1906, 2003.
21. 1A receptor null mice. J Am Soc Nephrol 10: 2620-2630, 1999.
22. Sadoshima J, Xu Y, Slayter HS, and Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
23. 2 judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation 104: 247-248, 2001.
24. Varagic J, Susic D, and Frohlich ED. Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors. Hypertension 37: 1399-1403, 2001.
25. 2 receptors: cardiovascular hope or hype? Br J Pharmacol 140: 809-824, 2003.
26. Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, de Gasparo M, and Horiuchi M. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 22: 49-54, 2002.
27. 1 antagonists in mice. Hypertension 40: 244-250, 2002.
28. 2 kinin receptor gene knockout mice. Circ Res 88: 1072-1079, 2001.
29. Yang Z, Berr SS, Gilson WD, Toufektsian MC, and French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in non-infarcted regions early after myocardial infarction. Circulation 109: 1161-1167, 2004.
30. Yang Z, Bove CM, French BA, Epstein FH, Berr SS, Dimaria JM, Gibson J, Carey RM, and Kramer CM. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 106: 106-111, 2002.